Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review

October 2021 | 55 pages | ID: A78DFE27B73EN
GlobalData

Abstracts

Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs drug delivery systems to advance drug compounds and drug delivery methods. It also focuses on product development programs in partnership with various leading pharmaceutical companies including Teva, Ferring Pharmaceuticals and AMAG. The company has presence in the US and Switzerland. Antares Pharma is headquartered in Mercer, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

Sep 08,2021: Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 05,2021: Antares Pharma Reports Second Quarter 2021 Financial and Operating Results
Jul 28,2021: Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
May 06,2021: Antares Pharma Reports First Quarter 2021 Financial and Operating Results
May 06,2021: Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Antares Pharma Inc - Key Facts
Antares Pharma Inc - Key Employees
Antares Pharma Inc - Key Employee Biographies
Antares Pharma Inc - Major Products and Services
Antares Pharma Inc - History
Antares Pharma Inc - Company Statement
Antares Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Antares Pharma Inc - Business Description
Business Segment: Licensing and Development
Performance
Business Segment: Product Sales
Performance
Business Segment: Royalties
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Antares Pharma Inc - Corporate Strategy
Antares Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Antares Pharma Inc - Strengths
Antares Pharma Inc - Weaknesses
Antares Pharma Inc - Opportunities
Antares Pharma Inc - Threats
Antares Pharma Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Antares Pharma Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 08, 2021: Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 05, 2021: Antares Pharma Reports Second Quarter 2021 Financial and Operating Results
Jul 28, 2021: Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
May 06, 2021: Antares Pharma Reports First Quarter 2021 Financial and Operating Results
May 06, 2021: Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
Apr 28, 2021: Antares Pharma to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
Apr 26, 2021: Antares Pharma appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
Apr 26, 2021: Antares Pharma appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
Mar 02, 2021: Antares Pharma reports fourth quarter and full-year 2020 financial and operating results
Feb 24, 2021: Antares Pharma to Present at Two Upcoming Investor Conferences

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Antares Pharma Inc, Key Facts
Antares Pharma Inc, Key Employees
Antares Pharma Inc, Key Employee Biographies
Antares Pharma Inc, Major Products and Services
Antares Pharma Inc, History
Antares Pharma Inc, Other Locations
Antares Pharma Inc, Subsidiaries
Antares Pharma Inc, Key Competitors
Antares Pharma Inc, Ratios based on current share price
Antares Pharma Inc, Annual Ratios
Antares Pharma Inc, Annual Ratios (Cont...1)
Antares Pharma Inc, Annual Ratios (Cont...2)
Antares Pharma Inc, Interim Ratios
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Antares Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Antares Pharma Inc, Performance Chart (2016 - 2020)
Antares Pharma Inc, Ratio Charts
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021